ADAR1 Capital Management »

Algonquin Power & Utilities equs shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Algonquin Power & Utilities equs (AQN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Algonquin Power & Utilities equs

Tip: Access up to 7 years of quarterly data

All positions including Algonquin Power & Utilities equs held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Algonquin Power & Utilities equs by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $316k 50k 6.32

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Algonquin Power & Utilities equs

Starboard Value
Vanguard Group
Bank Of Montreal
Royal Bank of Canada
Edgepoint Investment
Goldman Sachs Group
Bank of Nova Scotia
National Bank Of Canada /fi/
Legal & General Group
TD Asset Management
Intact Investment Management
Norges Bank Investment Management
Davidson Kempner Capital Management
Bank of America Corporation
British Columbia Investment Management Corporation

View all funds holding Algonquin Power & Utilities equs